1. Introduction {#s0005}
===============

Racial differences in the treatment and outcomes of patients with cardiovascular disease have long been acknowledged ([@bb0100], [@bb0075]). These disparities have drawn significant national attention and many calls for intervention to address them have been issued by influential organizations ([@bb0130], [@bb0010], [@bb0065], [@bb0060]). Regional variability in healthcare delivery is widely understood to occur and has sometimes been interpreted as a marker of variability in the quality of care leading to regional health disparities ([@bb0135], [@bb0035], [@bb0080], [@bb0040], [@bb0020], [@bb0115]). Interpreting regional variability as indicative of variable health care quality is particularly warranted when variability is observed in the delivery of evidence-based, guideline-recommended, practices, as is the case for patients who develop an acute coronary syndrome. Whether and how potential regional disparities in healthcare delivery and psychosocial/sociocultural factors are related to racial disparities in health status and outcomes is less well understood.

A limited number of observational studies in different regional settings have examined differences in the characteristics, treatment practices, and prognosis between African Americans (blacks) and European Americans (whites) who are discharged from the hospital after an acute coronary event ([@bb0115], [@bb0085], [@bb0110], [@bb0105], [@bb0095], [@bb0030], [@bb0120]); even fewer of these studies have had access to detailed psychometric data.

Using data from the TRACE-CORE (Transitions, Risks, and Actions in Coronary Events Center for Outcomes Research and Education) study ([@bb0125], [@bb0050], [@bb0090], [@bb0025]), we examined differences in the socio-demographic, clinical, and psychosocial characteristics, hospital treatment practices, and 30 day and 1 year death risks between white and black patients living in Central Massachusetts and Central Georgia following hospital discharge for an acute coronary syndrome (ACS).

2. Methods {#s0010}
==========

Details of the study design, patient recruitment practices, and data collection activities used in this longitudinal study have been described previously ([@bb0125], [@bb0050], [@bb0090], [@bb0025]).

In brief, TRACE-CORE used a multi-site prospective cohort design to recruit and follow a cohort of socioeconomically diverse adult men and women hospitalized with an ACS at 6 hospitals at study sites in Central Massachusetts and Georgia which served a heterogeneous and diverse patient population ([@bb0125], [@bb0050]). There were 2 major teaching hospitals and 1 community hospital in Worcester, MA, two Kaiser Permananete hospitals in Atlanta, GA, and a large teaching hospital in Macon, GA. There are a total of approximately 1100 licensed beds associated with the hospitals we recruited patients from in Central Massachusetts while the single hospital from which we recruited patients from in Macon, Georgia, is a 630 bed tertiary care community teaching hospital. Each of our study sites were affiliated with major teaching institutions including the University of Massachusetts Medical School (Worcester, Massachusetts) and the Mercer University School of Medicine (Mercer, Georgia). The University of Massachusetts Memorial Medical Center and Worcester Medical Center all have the capability of performing cardiac catheterization, percutaneous coronary interventions and coronary artery bypass surgery with similar cardiac diagnostic and interventional capabilities available at the Medical Center of Central Georgia. The city of Worcester, which is centrally located in Massachusetts, has a population of approximately 185,000 persons, 69% of whom are white, with a median household income of approximately \$45,000 based on recent census data; 22% of residents of this urban community are considered to be poor. The city of Macon lies centrally in Georgia and the population is approximately 150,000; 29% of residents of this more rural site are white. Based on recent census estimates, the median household income of city residents was approximately \$28,000 and 31% of the population was below the poverty line. All eligible and consenting adult patients discharged from participating hospitals after an ACS were enrolled between April 2011 and May 2013. Since there were so few black patients (n = 15) recruited from our Massachusetts site, we excluded these patients from the present analysis. We further excluded patients from our Atlanta site due to their relatively small number of eligible and consenting patients.

Trained study staff abstracted extensive socio-demographic, clinical, laboratory, physiologic, and treatment related data from the medical records of patients discharged from the hospital with an independently validated ACS. Standard definitions of ST-segment elevation acute myocardial infarction (STEMI) and Non ST-segment elevation myocardial infarction/unstable angina (NSTEMI/UA) were used ([@bb0125], [@bb0050], [@bb0070]).

Trained staff performed structured interviews using validated instruments about patients\' general and condition-specific quality of life, behavioral and lifestyle characteristics, and a variety of social factors. We queried patients using standardized instruments about a variety of psychosocial factors which would not be routinely available or collected and recorded in hospital charts. These factors included cognitive status, depression, anxiety, measures of perceived stress and social support, and health literacy ([@bb0125]). Interviews were performed face-to-face during the index ACS hospitalization.

Information was also collected from the review of hospital charts about the in-hospital use of several evidence-based cardiac medications. These included the guideline recommended therapies of angiotensin converting enzyme inhibitors/angiotensin receptor blockers, anticoagulants, aspirin, and beta blockers during the initial 24 h of hospitalization while the use of anticoagulant agents was replaced by the receipt of lipid lowering medications at the time of hospital discharge; we also determined whether the patient underwent cardiac catheterization, a percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG) surgery during their index ACS admission. Follow-up of all study patients for post-discharge mortality was carried out through the review of hospital discharge medical records, standardized telephone calls, and state and local review of death records.

3. Data analysis {#s0015}
================

We categorized our study sample into 3 categories: whites in Central Massachusetts and whites and blacks in Central Georgia. Given the socioeconomic gradient observed across these 3 categories, we treated the 3-value race/place variable as an ordinal variable. Differences in selected factors and study endpoints across these categories were examined using linear tests for trend and Cochran-Armitage trend tests for continuous and categorical variables, respectively.

We assumed that it was reasonable to consider the 3 level race/place variable as ordinal based on our conceptual understanding of the link between socio-economic status and the health outcomes under study in our patient population. We postulated a null hypothesis of no linear relationship between patient-level factors and our principal study endpoints with the 3 level race/place variable at the population level. We then used the Cochrane-Armitage trend statistic to test these null hypotheses of no linear association. This trend test statistic is equivalent to the score statistics from a linear logit model testing the null hypothesis of zero slope. Inasmuch, it is possible to have a significant test result rejecting the null hypothesis of zero slope even when the level of the outcome variable does not increase in lock-step with the predictor variable ([@bb0005]).

Ordinal logistic regression analysis accounted for a number of potentially confounding factors in examining differences in the hospital receipt of evidence-based cardiac medications, as well as 30 day and 1 year all-cause death risks, in white patients from Georgia, and black patients from Georgia, in comparison to the referent group of white patients from Massachusetts (see table footnotes for a list of covariates). We grouped the block of potential confounders into two blocks; first, we adjusted for demographic and socioeconomic factors and for comorbidities present at the time of hospital admission. The second block of controlling variables included physiologic parameters and psychosocial factors.

IRB approval was obtained from the Committee for the Protection of Human Subjects in Research at the University of Massachusetts Medical School and the other study sites and participating subjects provided written informed consent.

4. Results {#s0020}
==========

4.1. Study population characteristics {#s0025}
-------------------------------------

The study population consisted of 1143 whites discharged alive from three hospitals in Central Massachusetts and 514 whites and 277 blacks discharged after an ACS from the single hospital in Central Georgia. Among both whites and blacks, the majority was diagnosed with an NSTEMI/UA. The average hospital stay was 3.5 days for whites in MA and 5.3 and 5.0 days, respectively, for whites and blacks in Georgia.

The mean age of whites from both of our study sites was 5 years higher, these individuals were more frequently male and married, had higher levels of education, and were currently working than blacks hospitalized at the Medical Center of Central Georgia; the latter two factors also differed between whites in Massachusetts and Georgia as did differences in insurance coverage and body mass index between whites and blacks at our respective study sites ([Table 1](#t0005){ref-type="table"}). Whites in Georgia had lower educational attainment, health insurance coverage, and current employment than whites residing in Massachusetts but ranked higher on all these factors than blacks from Georgia; for body mass index, this ordering across the 3 race-region categories was reversed.

The 3-category ordinal gradient in terms of education, employment status, and receipt of Medicaid benefits was paralleled for many of the comorbidities noted at the time of hospital admission. Chronic kidney disease, coronary heart disease, prior receipt of a coronary revascularization procedure, diabetes, heart failure, hypertension, and stroke were least prevalent among whites in Central Massachusetts and most prevalent among blacks in Central Georgia.

In terms of physiologic factors, a three category ordinal gradient was not apparent, but blacks presented with higher mean blood pressures than whites (average of 5 to 8 mmHg higher) whereas whites had higher peak troponin findings than blacks; whites in Massachusetts had consistently higher levels of each of these factors than whites from Georgia ([Table 1](#t0005){ref-type="table"}).

Whites in Massachusetts were more likely than blacks or whites in Georgia to have chest pain/pressure as a presenting symptom (71% vs 62%). Black patients were more likely to have complained of dyspnea, nausea/vomiting, and fatigue than whites who were more likely to have complaints of diaphoresis and dizziness at hospital presentation ([Table 1](#t0005){ref-type="table"}).

There was considerable psychosocial distress manifest in our study population and less than desirable health literacy ([Table 2](#t0010){ref-type="table"}). In terms of race/place differences, there appeared to be a 3-category ordinal gradient for moderate/severe anxiety and depression, though blacks and whites in Georgia had relatively similar findings with regards to moderate/severe anxiety and depression, cognitive impairment (observed in almost 50% of blacks), perceived stress (\> 56% of blacks compared with approximately one third of whites in Massachusetts and 47% of whites in Georgia), health literacy, physical and mental health scores on the SF-36 assessment, social support, and alcohol consumption ([Table 2](#t0010){ref-type="table"}); while statistically significant, the mean differences in social support were relatively small, however, and of uncertain clinical significance

### 4.1.1. Hospital treatment practices {#s0030}

Whites from Massachusetts were more likely to have been treated with aspirin, anticoagulants, and antiplatelet therapy during the first 24 h of hospitalization than whites in Georgia, who were more likely to have been treated with these medications than blacks in Georgia. This race/place gradient was apparent for anticoagulants and antiplatelet therapy and for the prescription of all four evidenced-based cardiac therapies (36% of whites in Massachusetts, 18% of whites in Georgia, and approximately 1 in every 7 blacks in Georgia) ([Table 3](#t0015){ref-type="table"}). Differences in these medication prescribing practices at the time of hospital discharge also displayed the 3-category gradient observed previously; relatively similar differences were observed in the use of pre-ACS medications.

The gradient observed for other variables was noted for patients undergoing diagnostic cardiac catheterization and for the receipt of a percutaneous coronary intervention (PCI), though not for CABG surgery ([Table 3](#t0015){ref-type="table"}). White patients from Georgia were the most likely to have undergone CABG surgery during their acute hospitalization, whereas whites from Massachusetts were the least likely to have undergone this procedure.

We examined possible race/ethnicity and/or geographic differences in the receipt of all evidence-based cardiac medications and coronary interventional procedures while controlling for a variety of factors that could affect the receipt of these treatment strategies ([Table 4](#t0020){ref-type="table"}). The results of these analyses suggested that blacks and whites in Georgia were less likely than whites in Massachusetts to have been sent home on all four evidence-based cardiac medications and were less likely to have undergone a PCI. Blacks and whites in Central Georgia were more likely to have undergone CABG surgery during their hospitalization, but were less likely to have undergone any coronary revascularization procedure during their acute hospitalization than whites in Central Massachusetts. Virtually identical findings were observed when we controlled for the use of several pre-ACS medications.

We also compared blacks in Georgia with whites in Georgia (last column of [Table 4](#t0020){ref-type="table"}). After controlling for similar factors, blacks in Georgia were as likely as whites in this region to have been discharged on all four evidence-based cardiac medications. Blacks were less likely than whites to have undergone a PCI or CABG surgery in our unadjusted analyses, but these differences were attenuated after controlling for several medical history, clinical, physiologic, and psychosocial factors. However, receipt of any coronary revascularization approach (PCI and/or CABG surgery) during the patient\'s index admission was less frequent for blacks than whites in Georgia.

### 4.1.2. Thirty day and one year post discharge death risks {#s0035}

The 30-day and 1 year all-cause death risks were 0.4% and 2.9%, respectively, among whites in Massachusetts; 1.0% and 6.1% among whites in Georgia; and 1.4% and 6.0%, respectively, among blacks in Georgia ([Table 5](#t0025){ref-type="table"}).

After controlling for several previously described characteristics of prognostic importance, whites in Georgia had an increased odds of dying during the subsequent 30 days than whites in Massachusetts whereas blacks in Georgia experienced a higher odds of dying during the first 30 days after hospital discharge than whites in Massachusetts ([Table 5](#t0025){ref-type="table"}); similar findings were observed when we controlled for the receipt of hospital treatment practices and pre-ACS medications.

In terms of 1 year all-cause death risks, whites and blacks in Georgia had an increased odds of dying at this time point than whites in Massachusetts, both in our unadjusted analyses and after simultaneously controlling for a number of factors in our final regression model. One year post hospital discharge death risks were not different between whites and blacks at our Georgia site after controlling for several factors of prognostic importance ([Table 5](#t0025){ref-type="table"}).

5. Discussion {#s0040}
=============

The present findings illustrate a complex interplay of race and place with regard to differences in hospital presentation, hospital treatment practices/process measures, and 30 day and 1 year death risks for patients discharged from the hospital after an ACS. We observed a gradient in socio-demographic characteristics and access to care in which Georgia whites were intermediate between the most privileged (Massachusetts whites) and the least privileged (Georgia blacks). This gradient was paralleled by a similar gradient regarding the receipt of evidence-based care, with disparities remaining even after adjustment for multiple factors. Blacks and whites in Central Georgia fared worse than whites in Central Massachusetts with regard to 30 day and 1 year post discharge all-cause death risks. One needs to be careful, however, in the interpretation of the present findings since we did not have a comparison group of blacks from central Massachusetts, we lacked broader geographic representation of whites and blacks from other regions of the U.S., and our event rates were relatively low.

5.1. Patient characteristics {#s0045}
----------------------------

Black patients discharged from the hospital after an ACS in Georgia were relatively young, a lower proportion attended college, and a higher proportion had been previously diagnosed with several important comorbidities as compared with white patients at our Georgia and Massachusetts sites.

Similar differences in these characteristics between black and white patients were observed in the CRUSADE study ([@bb0085]). The \> 3000 black patients with an NSTEMI included in this investigation were several years younger than whites, and had a higher prevalence of previously diagnosed cardiovascular disease related comorbidities ([@bb0085]). Similar findings were reported among those included in five large randomized clinical trials of patients with acute coronary disease carried out between 1990 and 2001 ([@bb0095]).

While the reasons for these differences are unknown, it was of interest to note the higher blood pressure findings and peak troponin levels among whites hospitalized with an ACS in Central Massachusetts as compared with whites in Central Georgia. This could have been due to differences in patient\'s care seeking behavior, number, timing, and accuracy of these measurements, or to the severity of the acute coronary episode.

In comparing our results to these and other investigations, it is important to note that the other cited studies are somewhat dated and one study included a narrowly defined patient population. The TRACE-CORE investigation is a contemporary prospective cohort study that included patients across the spectrum of an ACS, with a wide range of socioeconomic diversity.

5.2. Psychosocial and behavioral characteristics {#s0050}
------------------------------------------------

There was considerable psychosocial distress and vulnerability reported by our study population. A considerable proportion of patients had anxiety and depression and poor health literacy and a wide range of cognitive impairment was observed. It needs to be noted, however, that in many of the study patients, their psychological distress may have been transient and a reaction to their acute illness and hospitalization while in others, their anxiety and depression may persist after hospital discharge; it is unknown how these psychosocial patterns may have differed according to race and study location.

Black patients were more likely to have moderate/severe symptoms of depression, be cognitively impaired, have higher levels of perceived stress, have poorer health literacy, be current smokers, and reported consuming either none or more moderate amounts of alcohol as compared with white patients. On the other hand, white patients discharged from the hospital after an ACS reported a higher quality of life but higher prevalence of lifetime depression than blacks.

Few clinical/epidemiologic studies have examined differences in various psychosocial factors or lifestyle characteristics between white and black patients hospitalized with an ACS ([@bb0115], [@bb0085], [@bb0095]). In the PREMIER study of \> 1800 patients hospitalized with an acute myocardial infarction (AMI) in 10 hospitals in California and Missouri, black patients presented with a worse psychosocial profile and poorer quality of life than white patients ([@bb0115]). Similarly, in the TRIUMPH study, patients with higher scores on the perceived stress scale were more likely to be non-white ([@bb0005]).

With regard to lifestyle factors, we found that a lower proportion of patients from Georgia reported consuming alcohol but a higher proportion were current smokers as compared with whites in Massachusetts. Investigators in the CRUSADE, GUSTO/ASSENT, and PREMIER studies found a higher proportion of current smokers in black than in white patients ([@bb0115], [@bb0085], [@bb0095]).

Given the high frequency and associated burden of psychosocial vulnerability demonstrated in our relatively young study population, health care providers should consider screening for these important lifestyle and psychosocial factors in all patients who develop an ACS. These factors have been associated with failure to understand post-discharge medication and lifestyle change instructions, the progressive nature of the patient\'s underlying disease process, long-term adherence to effective cardiac medications, and worse long-term outcomes.

5.3. Hospital treatment practices {#s0055}
---------------------------------

We observed a relatively lower utilization of effective cardiac medications in patients from Georgia during the initial 24 h of their hospitalization for an ACS and at the time of hospital discharge with no differences noted between blacks and whites at our Georgia site. A lower proportion of patients from Georgia underwent some form of coronary revascularization than whites from Massachusetts with black patients from Georgia being less likely to have undergone either a PCI or CABG surgery during their index hospitalization than whites from this region. While the reasons for these differences are unknown, the hospital length of stay was considerably longer for patients hospitalized with an ACS in Central Georgia as compared with Central Massachusetts, on average nearly 2 days longer. This may reflect differences in the severity of disease, hospital discharge policies and timing of admission and/or discharge, or in other factors between the 2 study sites.

In the CRUSADE study, black patients were less likely to have been prescribed evidence-based cardiac medications than whites and to have undergone cardiac catheterization and a PCI during their hospitalization ([@bb0110]). Black patients in the PREMIER study were significantly less likely to have undergone cardiac catheterization, PCI, and CABG surgery than whites and were also less likely to have been treated with evidence-based medications at hospital discharge ([@bb0115]).

Geographic differences have been observed with regards to the receipt of various cardiac medications and coronary interventional procedures among patients with cardiovascular and cerebrovascular disease in the U.S. ([@bb0035], [@bb0015], [@bb0045], [@bb0140]) In the REGARDS study of middle-aged and older adults living in the U.S. stroke belt ([@bb0045]), one third of study participants reported prophylactic aspirin use, with this usage being significantly more common among whites than blacks.

These and other findings that have been observed with regards to race and place in terms of the descriptive epidemiology of CHD need to be cautiously interpreted, however, given the effects of assessing one acute illness episode in a complex disease process. Racial as well as geographic disparities in the management and outcomes of patients hospitalized with an ACS may be due to patient\'s health insurance coverage and extent of financial resources, socio-cultural and racial biases and response to the underlying and acute disease state, acute presenting symptoms, extent of delay in seeking acute medical care, residual confounding by other factors, differences in the severity of acute coronary disease, or to the reluctance of certain patient subgroups to undergo cardiac interventional procedures or be medically treated in an aggressive manner ([@bb0055]).

5.4. Post discharge mortality risks {#s0060}
-----------------------------------

Researchers in the ARIC study, GUSTO, ASSENT, and PREMIER failed to find significant differences in the in-hospital, 30-day, or 1-year mortality rates between whites and blacks after adjusting for several potential confounding variables of prognostic importance ([@bb0115], [@bb0030]). In the CRUSADE study, blacks had lower 30-day multivariable adjusted death rates but similar 1-year death rates ([@bb0110]).

Both black and white patients from our site in Georgia were at higher risk for dying at 30 days and 1 year post hospital discharge than patients hospitalized for an ACS in Massachusetts. While there were no differences noted between blacks and whites at our Georgia site with regard to post hospital discharge death rates, blacks in Georgia were at greater odds for dying at 30 days after hospital discharge than whites in Massachusetts.

The present findings need to be cautiously interpreted, however, since a myriad of post discharge factors that may influence patient\'s downstream outcomes need to be considered in the interpretation of race and/or geographic differences in post discharge death risks after hospital discharge for an ACS. Moreover, the 30 day and 1 year risks of dying observed in the present study were relatively low and, as such, any between group/site differences need to be cautiously interpreted.

Factors to consider in explaining any possible race/place differences in the prognosis of patients after an ACS include the trajectory of the patient\'s underlying condition prior to the index event, adherence to cardiac medications prescribed and receipt of subsequent cardiac interventional procedures, physician follow-up after hospital discharge, social and financial support, and changes in psychosocial and lifestyle factors over time.

5.5. Study strengths and limitations {#s0065}
------------------------------------

The strengths of the present prospective study include the large and diverse sample of patients hospitalized with an ACS and use of standardized data collection instruments to ascertain various measures of psychosocial and lifestyle characteristics. As mentioned previously, however, our findings need to be carefully interpreted with appropriate reservation. The role of multimorbidity in these patients and studying a single clinical event in a complex condition and its natural history need to be considered in the evaluation of our study results. Unfortunately, the demographic characteristics of residents of Central Massachusetts are such that we could not conduct meaningful analyses on racial disparities within Massachusetts. We also cannot exclude the possible roles of information bias in eliciting possible differential responses to our baseline, in-hospital, study questionnaires according to race and place, possible selection bias in the characteristics of participating study subjects, and the role of other potentially confounding factors that we either did not collect information on, or were inadequately measured, such as health insurance or socioeconomic status, family support and situational factors, and extent of knowledge about ACS and its treatment.

6. Conclusions {#s0070}
==============

The results of this contemporary cohort study provide insights into the presenting symptoms, socio-demographic, psychosocial, and clinical characteristics, hospital medical practices, and risk of dying in white and black patients discharged from the hospital after an ACS. Whites in Georgia were more socially disadvantaged and underwent less evidence-based care than whites in Massachusetts, and blacks in Georgia were even worse off than whites in Georgia, thus perhaps placing them in "double jeopardy". These findings reinforce the need for more broadly based contemporary data and for additional research to try to understand what may be causal explanations including system and physician level variables as well as financial factors.

We are indebted to the trained study staff at each of our participating study sites as well as members of our Observational Study Monitoring Board.
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###### 

Population baseline characteristics according to race and place: TRACE-CORE.

Table 1.

  --------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                               Central MA\   Central GA\    Central GA\   p for trend                         
                                               Whites\       Whites\        Blacks\                                           
                                               (n = 1143)    (n = 514)      (n = 277)                                         
  -------------------------------------------- ------------- -------------- ------------- -------------- ----- -------------- ----------
  Age (mean, yrs (std))                        1143          62.3 (11.6)    514           61.8 (10.7)    277   57.1 (10.3)    \< 0.001

  Male                                         803           70.3           342           66.5           137   49.5           \< 0.001

  Married                                      703           61.5           311           60.5           102   36.8           \< 0.001

  Education                                                                                                                   

   High school or less                         454           39.8           273           53.1           194   70.0           \< 0.001

   Some college                                346           30.3           142           27.6           62    22.4           \< 0.001

   College graduate                            342           30.0           99            19.3           21    7.6            

   Currently working                           541           47.3           166           32.3           78    28.2           \< 0.001

  Insurance type                                                                                                              

   Medicaid                                    92            8.1            36            7.0            54    19.5           \< 0.001

   Medicare                                    153           13.4           111           21.6           53    19.1           \< 0.01

   Self-pay/no insurance                       59            5.2            68            13.2           44    25.7           \< 0.001

  Body mass index                                                                                                             

   \< 25                                       205           18.0           99            19.4           44    16.0           0.68

   25--29.9                                    430           37.8           164           32.2           67    24.4           \< 0.001

   ≥ 30                                        503           44.2           247           48.4           164   59.6           \< 0.001

  Medical history                                                                                                             

   ACS/MI                                      485           42.4           331           64.4           168   60.7           \< 0.001

   Revascularization procedure                 358           31.3           255           49.6           112   40.4           \< 0.001

   Atrial fibrillation                         96            8.4            53            10.3           16    5.8            0.50

   Chronic kidney disease                      108           9.5            60            11.7           48    17.3           \< 0.001

   Chronic lung disease                        200           17.5           112           21.8           48    17.3           0.46

   Depression                                  175           15.3           52            10.1           18    6.5            \< 0.001

   Diabetes                                    312           27.3           165           32.1           115   41.5           \< 0.001

   Heart failure                               108           9.5            104           20.2           68    24.6           \< 0.001

   Hyperlipidemia                              800           70.0           351           68.3           188   67.9           0.40

   Hypertension                                810           70.9           414           80.5           246   88.8           \< 0.001

   Stroke                                      36            3.2            34            6.6            32    11.6           \< 0.001

  Admission physiologic factors (mean (std))                                                                                  

  Systolic blood pressure (mm Hg)              1132          141.3 (25.0)   512           138.5 (25.3)   277   146.5 (30.7)   \< 0.001

  Diastolic systolic blood pressure\           1129          80.2 (25.3)    510           78.0 (17.6)    277   83.7 (19.7)    \< 0.05
  (mm Hg)                                                                                                                     

  eGFR (ml/min/1.73m^2^)                       1129          79.9 (24.6)    487           77.4 (33.0)    270   79.3 (36.8)    0.77

  Heart rate (bpm)                             1132          77.3 (19.1)    510           78.4 (18.1)    276   79.6 (19.9)    0.07

  Serum cholesterol (mg/dl)                    882           173.7 (46.1)   433           168.5 (55.8)   235   176.7 (52.1)   0.42

  Serum glucose (mg/dl)                        1080          152.1 (72.7)   496           152.4 (80.8)   275   149.4 (72.4)   0.60

  Maximum troponin I (ng/mL)                   847           22.7 (36.7)    454           12.6 (27.3)    250   11.3 (27.2)    \< 0.001

  Presenting symptoms                                                                                                         

   Chest pain/pressure                         815           71.3           318           61.9           171   61.7           \< 0.001

   Diaphoresis                                 263           23.0           81            15.8           55    19.9           \< 0.05

   Dizziness                                   128           11.2           39            7.6            22    7.9            \< 0.05

   Dyspnea                                     425           37.2           199           38.7           138   49.8           \< 0.001

   Nausea/vomiting                             216           18.9           125           24.3           78    28.2           \< 0.01

   Palpitations                                42            3.7            26            5.1            17    6.1            \< 0.05

   Weakness/fatigue                            84            7.4            62            12.1           34    12.3           \< 0.01
  --------------------------------------------------------------------------------------------------------------------------------------

eGFR -- estimated glomerular filtration rate.

###### 

Baseline psychosocial factors according to race and place: TRACE-CORE.

Table 2.

  ---------------------------------------------------------------------------------------------------------------------------------------------------
  Psychosocial and lifestyle factors                            Central MA\   Central GA\   Central GA\   p for trend                      
                                                                Whites\       Whites\       Blacks\                                        
                                                                (n = 1143)    (n = 514)     (n = 277)                                      
  ------------------------------------------------------------- ------------- ------------- ------------- ------------- ----- ------------ ----------
  Moderate/severe anxiety[a](#tf0005){ref-type="table-fn"}      226           19.8          157           30.5          78    28.2         \< 0.001

  Moderate/severe depression[b](#tf0010){ref-type="table-fn"}   186           16.3          151           29.4          83    30.0         \< 0.001

  Cognitively impaired[c](#tf0015){ref-type="table-fn"}         122           10.7          129           25.1          136   49.1         \< 0.001

  High perceived stress[d](#tf0020){ref-type="table-fn"}        360           32.3          240           47.2          153   56.3         \< 0.001

  Health literacy (good)[e](#tf0025){ref-type="table-fn"}       777           68.3          297           58.0          142   51.5         \< 0.001

  Low social support                                            63            5.5           27            5.3           22    7.9          0.22

  PCS (mean(std))[f](#tf0030){ref-type="table-fn"}              1143          44.0(10.3)    514           36.7(10.9)    277   37.5(10.3)   \< 0.001

  MCS (mean(std))[f](#tf0030){ref-type="table-fn"}              1143          49.3(11.3)    514           45.1(14.3)    277   44.6(13.1)   \< 0.001

  Social support (mean(std))                                    1128          20.6(4.5)     510           20.0(4.0)     275   18.6(4.7)    \< 0.001

  No Alcohol consumption                                        380           33.3          285           55.6          167   60.3         \< 0.001

  Rare/occasional drinker                                       457           40.1          147           28.7          74    26.7         \< 0.001

  Moderate/heavy alcohol consumption                            304           26.6          81            15.8          36    13.0         \< 0.001

  Current smoker                                                231           20.2          155           30.2          80    28.9         \< 0.001

  Prior smoker                                                  563           49.3          223           43.4          92    33.2         \< 0.001

  Nonsmoker                                                     349           30.5          136           26.5          105   37.9         0.17
  ---------------------------------------------------------------------------------------------------------------------------------------------------

MCS - mental health component summary score.

PCS - physical health component summary score.

GAD7 general anxiety disorder 7 item score: 5--9 mild, 10--14 moderate, ≥ 15 severe anxiety.

PHQ-9 patient health questionnaire 9 item score: 5--9 mild, 10--14 moderate, 15--19 moderately severe, and ≥ 20 severe depression.

TICS -- telephone interview for cognitive status: ≤ 28 impaired cognition.

Perceived stress scale: ≥ 20 high perceived stress.

Somewhat/not at all confident/little confidence in filling out medical forms.

SF-36 -- mental health and physical health components.

###### 

Hospital treatment practices according to race and place: TRACE-CORE.

Table 3.

  -------------------------------------------------------------------------------------------------------------------------------------------------------
  Medications administered within 24 h of hospital arrival                Central MA\   Central GA\   Central GA\   p for trend                
                                                                          Whites\       Whites\       Blacks\                                  
                                                                          (n = 1143)    (n = 514)     (n = 277)                                
  ----------------------------------------------------------------------- ------------- ------------- ------------- ------------- ----- ------ ----------
  Aspirin                                                                 949           83.0          413           80.4          208   75.1   \< 0.01

  Anticoagulants                                                          762           66.7          246           47.9          128   46.2   \< 0.001

  Antiplatelets                                                           763           66.8          283           55.1          137   49.5   \< 0.001

  Beta blockers                                                           873           76.4          383           74.5          203   73.3   0.23

  All 4 evidence-based cardiac therapies                                  406           35.5          93            18.1          40    14.4   \< 0.001

  Discharge medications                                                                                                                        

   Aspirin                                                                1121          98.1          466           90.7          234   84.5   \< 0.001

   ACE inhibitors                                                         623           54.5          196           38.1          120   43.3   \< 0.001

   Beta blockers                                                          1053          92.1          433           84.2          227   82.0   \< 0.001

   Lipid lowering medications                                             1105          96.7          452           87.9          234   84.5   \< 0.001

   All 4 evidence-based cardiac therapies                                 565           49.4          141           27.4          73    26.4   \< 0.001

  Diagnostic/interventional procedures                                                                                                         

   Cardiac catheterization                                                1106          96.8          490           95.3          251   90.6   \< 0.001

   Percutaneous coronary intervention                                     836           73.1          313           60.9          144   52.0   \< 0.001

   Coronary artery bypass surgery                                         117           10.2          94            18.3          41    14.8   \< 0.001

   Percutaneous coronary intervention or coronary artery bypass surgery   945           82.7          397           77.2          181   65.3   \< 0.001
  -------------------------------------------------------------------------------------------------------------------------------------------------------

ACE -- angiotensin-converting enzyme.

###### 

Crude and multivariable adjusted odds ratios (95% confidence intervals) for hospital treatment practices according to race and place: TRACE-CORE.

Table 4.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                        Central MA\         Central GA\   Central GA\   Central GA Blacks vs. Central GA Whites[c](#tf0045){ref-type="table-fn"}
                                                                        Whites\             Whites\       Blacks\       
                                                                        (n = 1143)          (n = 514)     (n = 277)     
  --------------------------------------------------------------------- ------------------- ------------- ------------- --------------------------------------------------------------------------
  Receipt of all evidence-based medications at hospital discharge (%)   49.4                27.4          26.4          27.1

  Unadjusted odds ratios (OR\'s)                                        1.0\                0.39\         0.37\         0.95\
                                                                        (Reference group)   (0.31,0.49)   (0.27,0.49)   (0.68,1.32)

  Regression Model 1[a](#tf0035){ref-type="table-fn"}                   1.0                 0.37\         0.33\         0.90\
                                                                                            (0.29,0.47)   (0.24,0.46)   (0.63,1.27)

  Regression model 2[b](#tf0040){ref-type="table-fn"}                   1.0                 0.38\         0.35\         0.91\
                                                                                            (0.29,0.50)   (0.24,0.50)   (0.63,1.32)

  Receipt of PCI (%)                                                    73.1                60.9          52.0          57.8

  Unadjusted OR\'s                                                      1.0\                0.57\         0.40\         0.70\
                                                                        (Reference group)   (0.46,0.71)   (0.30,0.52)   (0.52,0.93)

  Regression model 1[a](#tf0035){ref-type="table-fn"}                   1.0                 0.63\         0.47\         0.75\
                                                                                            (0.50,0.80)   (0.34,0.64)   (0.54,1.03)

  Regression model 2[b](#tf0040){ref-type="table-fn"}                   1.0                 0.68\         0.52\         0.77\
                                                                                            (0.52,0.88)   (0.37,0.74)   (0.54,1.08)

  Receipt of CABG surgery (%)                                           10.2                18.3          14.8          17.1

  Unadjusted OR\'s                                                      1.0\                1.96\         1.52\         0.78\
                                                                        (Reference group)   (1.46,2.63)   (1.04,2.23)   (0.52,1.16)

  Regression model 1[a](#tf0035){ref-type="table-fn"}                   1.0                 2.19\         1.56\         0.71\
                                                                                            (1.59,3.02)   (1.00,2.43)   (0.46,1.10)

  Regression model 2[b](#tf0040){ref-type="table-fn"}                   1.0                 1.99\         1.50\         0.75\
                                                                                            (1.40,2.83)   (0.93,2.43)   (0.47,1.21)

  Receipt of PCI or CABG surgery (%)                                    82.7                77.2          65.3          73.7

  Unadjusted OR\'s                                                      1.0\                0.71\         0.40\         0.56\
                                                                        (reference group)   (0.55,0.92)   (0.30,0.53)   (0.40,0.77)

  Regression model 1[a](#tf0035){ref-type="table-fn"}                   1.0                 0.87\         0.49\         0.57\
                                                                                            (0.66,1.15)   (0.35,0.70)   (0.40,0.81)

  Regression Model 2[b](#tf0040){ref-type="table-fn"}                   1.0                 0.91\         0.55\         0.61\
                                                                                            (0.67,1.24)   (0.38,0.81)   (0.41,0.89)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CABG -- coronary artery bypass grafting.

PCI -- percutaneous coronary intervention.

For each row, the first 3 columns present the multivariable adjusted odds ratios (95% confidence intervals) for an ordinal logistic regression model adjusting for age, sex, marital, education, health insurance, and employment status, body mass index, and medical history of chronic kidney disease, coronary heart disease, depression, diabetes, heart failure, hypertension, myocardial infarction, stroke, and prior coronary revascularization procedure. The last column presents the multivariable adjusted odds ratios (95% CIs) for a logistic regression model comparing blacks vs. whites in Central Georgia, adjusting for the same covariates.

For each row, the first 3 columns present the adjusted odds ratios (95% confidence intervals) for an ordinal logistic regression model adjusting for covariates listed above plus type of acute coronary syndrome, admission systolic and diastolic blood pressure and pulse findings, alcohol consumption, cigarette smoking, anxiety, depression, cognitive impairment, perceived stress, living situation, health literacy, and SF-36 scores. The last column presents the multivariable adjusted odds ratios (95% CIs) for a logistic regression model comparing blacks vs. whites in Central Georgia, adjusting for the same covariates.

Reference category = Central Georgia whites.

###### 

Crude and multivariable adjusted odds ratios (95% confidence intervals) for post discharge death rates according to race and place: TRACE-CORE.

Table 5.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                        Central MA\         Central GA\    Central GA\    Central GA Blacks vs Central GA Whites[c](#tf0060){ref-type="table-fn"}
                                                        Whites\             Whites\        Blacks\        
                                                        (n = 1143)          (n = 514)      (n = 277)      
  ----------------------------------------------------- ------------------- -------------- -------------- -------------------------------------------------------------------------
  30 Day all-cause mortality (%)                        0.4                 1.0            1.4            1.10

  Unadjusted OR\'s                                      1.0\                2.80\          4.17\          1.49\
                                                        (reference group)   (0.75,10.46)   (1.04,16.79)   (0.40,5.60)

  Regression model 1[a](#tf0050){ref-type="table-fn"}   1.0                 3.52\          7.83\          2.22\
                                                                            (0.86,14.44)   (1.36,45.00)   (0.46,10.75)

  Regression model 2[b](#tf0055){ref-type="table-fn"}   1.0                 5.71\          8.82\          1.55\
                                                                            (0.94,34.65)   (1.03,75.86)   (0.25,9.69)

  1 year All-cause mortality (%)                        2.9                 6.1            6.0            6.1

  Unadjusted OR\'s                                      1.0\                2.21\          2.16\          0.98\
                                                        (Reference group)   (1.29,3.77)    (1.14,4.10)    (0.51.1.88)

  Regression model 1[a](#tf0050){ref-type="table-fn"}   1.0                 1.78\          1.65\          0.93\
                                                                            (0.97,3.26)    (0.75,3.63)    (0.44,1.96)

  Regression model 2[b](#tf0055){ref-type="table-fn"}   1.0                 1.48\          1.61\          1.09\
                                                                            (0.76,2.88)    (0.67,3.85)    (0.47,2.52)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Adjusted for age, sex, marital, education, health insurance, and employment status, body mass index, and medical history of chronic kidney disease, coronary heart disease, depression, diabetes, heart failure, hypertension, myocardial infarction, stroke and prior coronary revascularization procedure.

Adjusted for covariates listed above plus type of acute coronary syndrome, admission systolic and diastolic blood pressure and pulse findings, alcohol consumption, cigarette smoking, anxiety, depression, cognitive impairment, perceived stress, living situation, health literacy, and SF-36 scores.

Reference category = Central Georgia whites.
